Chemical Property of Nemonoxacin
Chemical Property:
- Boiling Point:606.4±55.0 °C(Predicted)
- PKA:6.52±0.50(Predicted)
- PSA：97.79000
- Density:1.335±0.06 g/cm3(Predicted)
- LogP:2.98200
- XLogP3:0.4
- Hydrogen Bond Donor Count:2
- Hydrogen Bond Acceptor Count:7
- Rotatable Bond Count:4
- Exact Mass:371.18450629
- Heavy Atom Count:27
- Complexity:647
- Purity/Quality:
-
98% ,99% , *data from raw suppliers
NEMONOXACIN 95.00% *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:CC1CC(CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N
- Isomeric SMILES:C[C@H]1C[C@@H](CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N
- Recent ClinicalTrials:Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia
-
Description
Nemonoxacin is a novel
nonfluorinated quinolone and broad-spectrum antibiotic for the
treatment of drug-resistant bacterial infections, including
methicillin-resistant Staphylococcus aureus (MRSA) and quinolone-
resistant MRSA as well as quinolone-resistant Streptococcus
pneumonia. The drug was originally discovered by Procter &
Gamble Pharmaceuticals (P&GP). It was codeveloped by
TaiGen Biotechnology for development in Asia and by Warner
Chilcott for development in the United States and Europe and
was first approved by the China Food and Drug Administration
(CFDA).
